Skin Cancer Home > Zelboraf Warnings and Precautions
Allergic reactions, liver damage, or heart problems may occur in some people who take Zelboraf. Other safety precautions with this drug involve warnings of drug interactions and potential risks of taking this medication while pregnant or breastfeeding. Before beginning Zelboraf treatment, make sure your healthcare provider is aware of your complete medical history, particularly if you have an irregular heartbeat or a history of skin cancer.
What Should I Tell My Healthcare Provider?You should talk with your healthcare provider prior to taking Zelboraf™ (vemurafenib) if you have:
- Liver disease, such as hepatitis, cirrhosis, or liver failure
- Kidney disease, such as kidney failure
- A history of skin cancer
- Frequent sun exposure
- An irregular heartbeat
- A heart condition known as QT prolongation or long QT syndrome
- Been told you have low blood electrolytes, such as low blood magnesium, calcium, or potassium levels
- Eye problems, including eye conditions known as uveitis or iritis
- Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.